Ropes & Gray advised Kailera Therapeutics, Inc. on the transaction. Kailera Therapeutics, Inc. (“Kailera”) announced raising $400 million in Series A financing. Kailera announced its launch...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here